See also this year's filing and all EDGAR filings for this company.
PDF Report 0001176309_2025_Oramed_Pharmaceuticals_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| info | Ambiguous roles for statement | input.sec.calculation_linkbase.expand_agg | {'statement': 'operations', 'valid_roles': {'995303 - Statement - Consolidated Statements of Comprehensive Income (Loss)': 9, '995303 - Statement - Consolidated Statements of Comprehensive Income (Loss) Alternate 0': 2}} |
Graph
Absolute values for 0001176309, Oramed Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 143,221,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 698,000 |
| 3 | remainder_Assets | 11,359,000 |
| 4 | LiabilitiesCurrent | 5,685,000 |
| 5 | LiabilitiesNoncurrent | 4,246,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 6,789,849 |
| 9 | ResearchAndDevelopmentExpense | 6,175,253 |
| 10 | remainder_Expenses | 5,338,188 |
| 11 | remainder_Revenues | -1,507,427 |
| 12 | remainder_NetIncome | 5,049,929 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 155,278,000 |
| 1 | Liabilities | 9,931,000 |
| 2 | Expenses | 18,303,290 |
| 3 | Revenues | -1,507,427 |
| 4 | StockholdersEquity | 145,347,000 |
| 5 | NetIncome | -14,760,788 |
| 6 | ComprehensiveNetIncome | -14,760,788 |
| 7 | BaseVar | 95,034,823 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.66 |
| 9 | EconomicCapitalRatio | 4.14 |
Edgar->Model Mapping
Feature Distribution
Change over Time
